• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全面泛癌分析揭示 ENC1 作为肿瘤微环境和治疗反应有前途的预后生物标志物。

Comprehensive pan-cancer analysis reveals ENC1 as a promising prognostic biomarker for tumor microenvironment and therapeutic responses.

机构信息

Department of Hepatobiliary Surgery, Hunan Provincial People's Hospital, First Affiliated Hospital of Hunan Normal University, Changsha, Hunan Province, China.

Hunan Provincial Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations, Changsha Medical University, Changsha, Hunan Province, China.

出版信息

Sci Rep. 2024 Oct 25;14(1):25331. doi: 10.1038/s41598-024-76798-9.

DOI:10.1038/s41598-024-76798-9
PMID:39455818
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11512054/
Abstract

Accumulating research showed that ENC1 plays a critical role in maintaining the physiological functions. However, little is known about its role in predicting prognosis and immunotherapy response across cancers. In our results, compared to normal tissues, most cancer tissues exhibit increased ENC1 expression. We found that the most common type of genetic variation was gene mutation. In addition, a positive correlation was found between CNV and ENC1 expression. Moreover, the overexpression of ENC1 was positively correlated with poor clinical outcomes. The GSEA results showed that ENC1 is closely correlated with tumor-promoting biological functions in most cancers. ENC1 is also closely negatively associated with the infiltration levels of T cells, activated NK cells, and B cells. Most immunomodulators are positively associated with ENC1. Further, we verified that inhibition of ENC1 expression suppressed the proliferation and migration of breast cancer, pancreatic cancer and glioma cells. In conclusion, our study demonstrated that ENC1 plays a protumorigenic role in most cancers. Additionally, ENC1 is closely correlated with tumor microenvironment features and immune checkpoint inhibitors expression. Overall, ENC1 could serve as a promising potential prognostic biomarker in various tumors.

摘要

越来越多的研究表明,ENC1 在维持生理功能方面起着关键作用。然而,关于其在预测癌症预后和免疫治疗反应中的作用知之甚少。在我们的研究结果中,与正常组织相比,大多数癌症组织表现出 ENC1 表达增加。我们发现最常见的遗传变异类型是基因突变。此外,还发现 CNV 与 ENC1 表达之间存在正相关。此外,ENC1 的过表达与不良临床结局呈正相关。GSEA 结果表明,ENC1 与大多数癌症中促进肿瘤的生物学功能密切相关。ENC1 也与 T 细胞、活化 NK 细胞和 B 细胞的浸润水平密切负相关。大多数免疫调节剂与 ENC1 呈正相关。此外,我们验证了抑制 ENC1 的表达可抑制乳腺癌、胰腺癌和神经胶质瘤细胞的增殖和迁移。总之,我们的研究表明,ENC1 在大多数癌症中起致癌作用。此外,ENC1 与肿瘤微环境特征和免疫检查点抑制剂表达密切相关。总的来说,ENC1 可以作为各种肿瘤有前途的潜在预后生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b40/11512054/7cf8baf0d0aa/41598_2024_76798_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b40/11512054/9285b7e86efb/41598_2024_76798_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b40/11512054/1d028c9a18da/41598_2024_76798_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b40/11512054/8b533ac0bcd5/41598_2024_76798_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b40/11512054/b83cd0553b4b/41598_2024_76798_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b40/11512054/16b8e78b450f/41598_2024_76798_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b40/11512054/def0ae24bd2a/41598_2024_76798_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b40/11512054/05a2a319db7e/41598_2024_76798_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b40/11512054/691c6b980ac1/41598_2024_76798_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b40/11512054/7cf8baf0d0aa/41598_2024_76798_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b40/11512054/9285b7e86efb/41598_2024_76798_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b40/11512054/1d028c9a18da/41598_2024_76798_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b40/11512054/8b533ac0bcd5/41598_2024_76798_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b40/11512054/b83cd0553b4b/41598_2024_76798_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b40/11512054/16b8e78b450f/41598_2024_76798_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b40/11512054/def0ae24bd2a/41598_2024_76798_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b40/11512054/05a2a319db7e/41598_2024_76798_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b40/11512054/691c6b980ac1/41598_2024_76798_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b40/11512054/7cf8baf0d0aa/41598_2024_76798_Fig9_HTML.jpg

相似文献

1
Comprehensive pan-cancer analysis reveals ENC1 as a promising prognostic biomarker for tumor microenvironment and therapeutic responses.全面泛癌分析揭示 ENC1 作为肿瘤微环境和治疗反应有前途的预后生物标志物。
Sci Rep. 2024 Oct 25;14(1):25331. doi: 10.1038/s41598-024-76798-9.
2
VDR is a potential prognostic biomarker and positively correlated with immune infiltration: a comprehensive pan-cancer analysis with experimental verification.VDR 是一种潜在的预后生物标志物,与免疫浸润呈正相关:一项具有实验验证的全面泛癌分析。
Biosci Rep. 2024 May 29;44(5). doi: 10.1042/BSR20231845.
3
RREB1 could act as an immunological and prognostic biomarker: From comprehensive analysis to osteosarcoma validation.RREB1 可作为免疫和预后生物标志物:从综合分析到骨肉瘤验证。
Int Immunopharmacol. 2024 Dec 25;143(Pt 1):113312. doi: 10.1016/j.intimp.2024.113312. Epub 2024 Oct 14.
4
Comprehensive pan-cancer analysis of role of GPRASP1, associated with clinical outcomes, immune microenvironment, and immunotherapeutic efficiency in pancreatic cancer.全面泛癌分析 GPRASP1 作用,与胰腺癌临床结局、免疫微环境和免疫治疗效率相关。
Pathol Res Pract. 2023 Mar;243:154374. doi: 10.1016/j.prp.2023.154374. Epub 2023 Feb 12.
5
Comprehensive analysis of EphA2 in pan-cancer: A prognostic biomarker associated with cancer immunity.EphA2 在泛癌种中的综合分析:与癌症免疫相关的预后生物标志物。
Clin Exp Pharmacol Physiol. 2024 Aug;51(8):e13902. doi: 10.1111/1440-1681.13902.
6
Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2.对 33 种人类癌症的综合分析揭示了溶质载体家族 35 成员 A2 的临床意义和免疫治疗价值。
Front Immunol. 2023 May 18;14:1155182. doi: 10.3389/fimmu.2023.1155182. eCollection 2023.
7
A systematic pan-cancer analysis identifies LDHA as a novel predictor for immunological, prognostic, and immunotherapy resistance.一项系统性泛癌症分析确定 LDHA 为免疫、预后和免疫治疗耐药的新型预测因子。
Aging (Albany NY). 2024 May 3;16(9):8000-8018. doi: 10.18632/aging.205800.
8
Comprehensive pan-cancer analysis reveals NUSAP1 is a novel predictive biomarker for prognosis and immunotherapy response.全面泛癌分析揭示 NUSAP1 是一种新的预测预后和免疫治疗反应的生物标志物。
Int J Biol Sci. 2023 Sep 4;19(14):4689-4708. doi: 10.7150/ijbs.80017. eCollection 2023.
9
Comprehensive pan-cancer analysis reveals prognostic implications of TMEM92 in the tumor immune microenvironment.全面泛癌分析揭示了 TMEM92 在肿瘤免疫微环境中的预后意义。
Clin Transl Oncol. 2024 Oct;26(10):2701-2717. doi: 10.1007/s12094-024-03477-6. Epub 2024 Apr 20.
10
Pan-cancer evidence of prognosis, immune infiltration, and immunotherapy efficacy for annexin family using multi-omics data.基于多组学数据的膜联蛋白家族在泛癌中预后、免疫浸润和免疫治疗疗效的证据。
Funct Integr Genomics. 2023 Jun 26;23(3):211. doi: 10.1007/s10142-023-01106-z.

引用本文的文献

1
In Vitro Evaluation of Leaf Infusion as a Modulator of Antineoplastic Drug-Induced Cytotoxicity in Cancer Cell Lines.叶浸液作为癌细胞系中抗肿瘤药物诱导细胞毒性调节剂的体外评价
Pharmaceuticals (Basel). 2025 Aug 9;18(8):1177. doi: 10.3390/ph18081177.
2
Pan-cancer analysis of PTPN6: prognostic significance and functional implications in tumor progression.蛋白酪氨酸磷酸酶非受体型6的泛癌分析:肿瘤进展中的预后意义及功能影响
Discov Oncol. 2025 Aug 25;16(1):1611. doi: 10.1007/s12672-025-03384-4.
3
Exploring the critical role of SDHA in breast cancer proliferation: implications for novel therapeutic strategies.

本文引用的文献

1
Challenges and opportunities in cancer immunotherapy: a Society for Immunotherapy of Cancer (SITC) strategic vision.癌症免疫治疗的挑战与机遇:癌症免疫治疗学会(SITC)的战略愿景。
J Immunother Cancer. 2024 Jun 19;12(6):e009063. doi: 10.1136/jitc-2024-009063.
2
Reshaping immunometabolism in the tumour microenvironment to improve cancer immunotherapy.重塑肿瘤微环境中的免疫代谢以改善癌症免疫治疗。
Biomed Pharmacother. 2023 Aug;164:114963. doi: 10.1016/j.biopha.2023.114963. Epub 2023 Jun 2.
3
Potential non-invasive biomarkers in tumor immune checkpoint inhibitor therapy: response and prognosis prediction.
探索SDHA在乳腺癌增殖中的关键作用:对新型治疗策略的启示
Am J Transl Res. 2025 Jul 15;17(7):5221-5240. doi: 10.62347/XAKQ8090. eCollection 2025.
4
Beyond the Limit: MYC Mediates Tumor Immune Escape.突破极限:MYC介导肿瘤免疫逃逸。
Pharmaceuticals (Basel). 2025 Jun 29;18(7):978. doi: 10.3390/ph18070978.
5
Immuno-informatics analyses of important esophageal cancer associated viruses for multi-epitope vaccine design.用于多表位疫苗设计的重要食管癌相关病毒的免疫信息学分析
Front Immunol. 2025 Jul 8;16:1587224. doi: 10.3389/fimmu.2025.1587224. eCollection 2025.
6
Advanced finite segmentation model with hybrid classifier learning for high-precision brain tumor delineation in PET imaging.用于PET成像中高精度脑肿瘤轮廓描绘的具有混合分类器学习的先进有限分割模型。
Sci Rep. 2025 Jul 15;15(1):25666. doi: 10.1038/s41598-025-09638-z.
7
In silico and in vitro assessment of TP53, ATM, RAD51, and BAX genes in gastric cancer and their contribution to radiotherapy resistance.胃癌中TP53、ATM、RAD51和BAX基因的计算机模拟及体外评估及其对放疗抗性的影响
Hereditas. 2025 Jul 12;162(1):125. doi: 10.1186/s41065-025-00496-3.
8
Functions and mechanisms of long non-coding RNA in esophageal squamous cell carcinoma (Review).长链非编码RNA在食管鳞状细胞癌中的作用及机制(综述)
Oncol Lett. 2025 Jul 1;30(3):418. doi: 10.3892/ol.2025.15164. eCollection 2025 Sep.
9
Anticancer and antibacterial activity of the cellulose nanocrystals modified by cyclodextrin and loaded by propolis.环糊精修饰并负载蜂胶的纤维素纳米晶体的抗癌和抗菌活性
Sci Rep. 2025 Jul 10;15(1):24799. doi: 10.1038/s41598-025-08622-x.
10
Non-coding RNAs as key regulators in hepatitis B virus-related hepatocellular carcinoma.非编码RNA作为乙型肝炎病毒相关肝细胞癌的关键调节因子
Front Immunol. 2025 Jun 23;16:1602252. doi: 10.3389/fimmu.2025.1602252. eCollection 2025.
肿瘤免疫检查点抑制剂治疗中的潜在非侵入性生物标志物:反应与预后预测
Biomark Res. 2023 Jun 2;11(1):57. doi: 10.1186/s40364-023-00498-1.
4
Magnetic-Manipulated NK Cell Proliferation and Activation Enhance Immunotherapy of Orthotopic Liver Cancer.磁操控 NK 细胞增殖和激活增强原位肝癌的免疫治疗。
J Am Chem Soc. 2023 Jun 21;145(24):13147-13160. doi: 10.1021/jacs.3c02049. Epub 2023 Jun 1.
5
Targeted DNA Demethylation: Vectors, Effectors and Perspectives.靶向DNA去甲基化:载体、效应物与展望
Biomedicines. 2023 Apr 30;11(5):1334. doi: 10.3390/biomedicines11051334.
6
The current advances and future directions of PD-1/PD-L1 blockade in head and neck squamous cell carcinoma (HNSCC) in the era of immunotherapy.免疫治疗时代 PD-1/PD-L1 阻断在头颈部鳞状细胞癌(HNSCC)中的当前进展和未来方向。
Int Immunopharmacol. 2023 Jul;120:110329. doi: 10.1016/j.intimp.2023.110329. Epub 2023 May 17.
7
PDE4D/cAMP/IL-23 axis determines the immunotherapy efficacy of lung adenocarcinoma via activating the IL-9 autocrine loop of cytotoxic T lymphocytes.PDE4D/cAMP/IL-23 轴通过激活细胞毒性 T 淋巴细胞的 IL-9 自分泌环来决定肺腺癌的免疫治疗疗效。
Cancer Lett. 2023 Jul 1;565:216224. doi: 10.1016/j.canlet.2023.216224. Epub 2023 May 16.
8
: a powerful model organism to explore histone modifications and their upstream regulations.: 一种强大的模式生物,可用于探索组蛋白修饰及其上游调控。
Epigenetics. 2023 Dec;18(1):2211362. doi: 10.1080/15592294.2023.2211362.
9
Targeting molecular cross-talk between tumor cells and tumor associated macrophage as therapeutic strategy in triple negative breast cancer.针对三阴性乳腺癌中肿瘤细胞与肿瘤相关巨噬细胞之间的分子串扰作为治疗策略。
Int Immunopharmacol. 2023 Jun;119:110250. doi: 10.1016/j.intimp.2023.110250. Epub 2023 May 8.
10
Childhood Acute Lymphoblastic Leukemia: Results of the Randomized Acute Lymphoblastic Leukemia Intercontinental-Berlin-Frankfurt-Münster 2009 Trial.儿童急性淋巴细胞白血病:随机急性淋巴细胞白血病国际-柏林-法兰克福-慕尼黑 2009 试验的结果。
J Clin Oncol. 2023 Jul 1;41(19):3499-3511. doi: 10.1200/JCO.22.01760. Epub 2023 May 4.